NCT01962701

Completed

Fetal Copeptin After Oxytocin Challenge Test

University of Zurich Source

Other study identifiers

Sponsor study identifier

CopOCT

Study Type

observational

Actual enrollment (reported)

140

Locations

1 country

Sites

1

Timeline

Study Start

January 2013

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

June 2014

Actual (reported)

Study Completion

June 2014

Actual (reported)

Brief Summary

The relationship of uterine contractions on fetal copeptin levels in umbilical cord blood is studied.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 140 participants
Study completion date: June 2014
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 2013
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
October 10, 2013
Actual (reported)
First Posted
October 14, 2013
Actual (reported)
Primary Completion
June 2014
Actual (reported)
Study Completion
June 2014
Actual (reported)

Last Updated: May 10, 2016
Status Verified: May 2016
Last Update Submitted: May 9, 2016

Conditions

Pregnancy

Keywords

C-section

Outcome Measures

Primary Outcomes (1)

Fetal plasma copeptin concentration
To be determined in arterial umbilical cord blood at birth
30 min after delivery

Study Arms (2)

OCT-group

OCT prior to C-section

None-OCT-group

No OCT prior to C-section

Eligibility Criteria

Age18 Years - 50 Years

Sexfemale

Healthy VolunteersNo

Age GroupsAdult (18-64)

Sampling MethodProbability Sample

Study Population

Primary care hospital, healthy pregnant women presenting for delivery at term

You may qualify if:

Singleton pregnancy

Sponsors & Collaborators

University of Zurich
Otherlead

Study Sites (1)

University Hospital Zurich, Department of Obstetrics

Zurich, Canton of Zurich, 8091, Switzerland

Related Publications (1)

Wellmann S, Koslowski A, Spanaus K, Zimmermann R, Burkhardt T. Fetal Release of Copeptin in Response to Maternal Oxytocin Administration: A Randomized Controlled Trial. Obstet Gynecol. 2016 Oct;128(4):699-703. doi: 10.1097/AOG.0000000000001594.
PMID: 27607861DERIVED

Biospecimen

Retention: SAMPLES WITHOUT DNA

EDTA plasma of arterial umbilical cord blood

Study Officials

Tilo Burkhardt, MD
University Hospital Zurich, Department of Obstetrics
PRINCIPAL INVESTIGATOR

Enrollment

140 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

October 10, 2013

First Posted

October 14, 2013

Study Start

January 2013

Date type not reported

This date has not been verified as actual or estimated.

NCT01681498

Fetal Electrocardiogram Extraction-Pilot Study

Terminated

NCT02453230

The Effect of Light on the Fetal Biophysical Profile

Not ApplicableCompleted

NCT01165879

Measuring Uterine Electrical Activity Throughout Pregnancy and Labor Measuring Uterine Electrical Activity Throughout Pregnancy and Labor

Unknown

NCT02714556

Changes in Ventilation Inhomogeneity and Respiratory Function Following Elective Caesarean Section Under Regional Anaesthesia

Withdrawn

NCT01400880

Electrode-based Sensor for Non-invasive Fetal Heart Rate and EMG Monitoring With Improved Reliability

Early Phase 1Completed

NCT02622802

Transplacental Transfer of Drugs Used in Pregnant Women

Not ApplicableCompleted

Gestational age more than 36 weeks

No contractions reported within the last 24 hours

No contractions recorded by 30 min cardiotocogram prior to oxytocin challenge test

You may not qualify if:

All contraindications for labor, including placenta praevia
Serious fetal malformations
Anhydramnios
Oligohydramnios
IUGR \< 5. percentile
Presence of any contractions
Suspicious or pathological fetal heart rate tracing (cardiotocogram)
Any clinical or biochemical signs of maternal infection
Breech presentation
More than 1 C-section in history

Contact the study team to confirm eligibility.

Primary Completion

June 2014

Actual (reported)

Study Completion

June 2014

Actual (reported)

Last Updated

May 10, 2016

Record last verified: 2016-05

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01962701
Data provider: ClinicalTrials.gov
Source updated: 2016-05-10
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:26:37 UTC

Locations

CH(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

OCT-group

None-OCT-group

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

Biospecimen

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations